CymitQuimica logo

CAS 1097263-60-9

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
  • Bosentan Related Compound C (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane)

    CAS :
    Sulfonamides, nesoi
    Formule :C52H52N10O10S2
    Couleur et forme :Off-White Powder
    Masse moléculaire :1040.33093
  • Bosentan USP Related Compound C

    CAS :
    Formule :C52H52N10O10S2
    Couleur et forme :Pale Yellow Solid
    Masse moléculaire :1041.17

    Ref: 4Z-B-1210

    5mg
    À demander
    10mg
    910,00€
    25mg
    1.638,00€
    50mg
    2.366,00€
    100mg
    À demander
  • N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide

    Produit contrôlé
    CAS :
    <p>Impurity Bosentan USP Related Compound C<br>Applications N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide is an impurity of Bosentan (B675900), a mixed endothelin receptor antagonist. Bosentan USP Related Compound C.<br>References Clozel, M., et al.: J. Pharmacol. Exp. Ther., 270, 228 (1994), Gutsch, G., et al.: Cardiovasc. Drugs Ther., 10, 717 (1996), Weber, C., et al.: Clin Pharmacol. Ther., 60, 124 (1996), Krum, H., et al.: N. Engl. J. Med., 338, 784 (1998)<br></p>
    Formule :C52H52N10O10S2
    Couleur et forme :Neat
    Masse moléculaire :1041.16

    Ref: TR-E676300

    10mg
    1.530,00€
  • N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide-d4

    Produit contrôlé
    CAS :
    <p>Applications N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide-d4 is labelled N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide (E676300) which is an impurity of Bosentan (B675900), a mixed endothelin receptor antagonist.<br>References Clozel, M., et al.: J. Pharmacol. Exp. Ther., 270, 228 (1994), Gutsch, G., et al.: Cardiovasc. Drugs Ther., 10, 717 (1996), Weber, C., et al.: Clin Pharmacol. Ther., 60, 124 (1996), Krum, H., et al.: N. Engl. J. Med., 338, 784 (1998)<br></p>
    Formule :C52D4H48N10O10S2
    Couleur et forme :Neat
    Masse moléculaire :1045.185

    Ref: TR-E676302

    5mg
    1.530,00€
  • Bosentan impurity C

    CAS :
    <p>Bosentan impurity C is a stable crystalline compound that is soluble in organic solvents. It has been identified as an impurity of the drug bosentan, and has been found to be present in the drug at concentrations of up to 0.2%. Bosentan impurity C can be prepared by crystallization from an alkaline solution and can also be obtained as a salt form. The salt form is a dimer that consists of two bosentan molecules linked together by one oxygen atom. Bosentan impurity C is stable under normal conditions and does not undergo any changes when exposed to light or heat. This compound has shown no significant adverse effects on humans who have taken it, with no adverse effects on the kidney, liver, or lungs reported.</p>
    Formule :C52H52N10O10S2
    Degré de pureté :Min. 95%
    Masse moléculaire :1,041.16 g/mol

    Ref: 3D-IB64076

    50mg
    3.293,00€
    100mg
    5.185,00€
  • Bosentan USP Related Compound C

    CAS :
    Formule :C52H52N10O10S2
    Masse moléculaire :1041.17

    Ref: ST-EA-CP-B59004

    10mg
    À demander
    25mg
    À demander
    50mg
    À demander
    100mg
    À demander